Amgen (AMGN) PT Lowered to $281 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $414.87 +1.82%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Amgen (NASDAQ: AMGN) to $281.00 (from $285.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $380 at Truist Securities
- Zeta Global Holdings Corp (ZETA) PT Raised to $38 at Truist Securities
- Amgen (AMGN) PT Raised to $440 at Cantor Fitzgerald - 'Now a Clear Consensus Long'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
